Webinar Details
Trademarks and the FDA Pilot Program
Overview
Review of the 2 year pilot program intent, requirements for submission, what changes mean in clearing new pharmaceutical trademarks, approaches to trademark developments.
Details
By
Maurey Tepper, Tepper & Eyster, PPLC
Robert E. Lee Jr., Assistent General Patent Counsel, Patents Trademarks and Copyright, Eli Lilly and Company
James A. Thomas, Parner, Troutman Sanders LLP
Comments
Post new comment